Cargando…

Proteomic profiles of prevalent mild cognitive impairment and Alzheimer's disease among adults with Down syndrome

INTRODUCTION: We sought to determine if a proteomic profile approach developed to detect Alzheimer's disease (AD) in the general population would apply to adults with Down syndrome (DS). METHODS: Plasma samples were obtained from 398 members of a community‐based cohort of adults with DS. A tota...

Descripción completa

Detalles Bibliográficos
Autores principales:	Petersen, Melissa, Zhang, Fan, Krinsky‐McHale, Sharon J., Silverman, Wayne, Lee, Joseph H., Pang, Deborah, Hall, James, Schupf, Nicole, O'Bryant, Sid E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7233426/ https://www.ncbi.nlm.nih.gov/pubmed/32435687 http://dx.doi.org/10.1002/dad2.12023

Ejemplares similares

Proteomic profiles of incident mild cognitive impairment and Alzheimer's disease among adults with Down syndrome
por: O'Bryant, Sid E., et al.
Publicado: (2020)

Proteomic profiles for Alzheimer's disease and mild cognitive impairment among adults with Down syndrome spanning serum and plasma: An Alzheimer's Biomarker Consortium–Down Syndrome (ABC–DS) study
por: Petersen, Melissa E., et al.
Publicado: (2020)

Promising outcome measures of early Alzheimer's dementia in adults with Down syndrome
por: Krinsky‐McHale, Sharon J, et al.
Publicado: (2020)

Alzheimer's risk and quality of life: History of Down syndrome as a case in point
por: Silverman, Wayne, et al.
Publicado: (2021)

Individualized estimated years from onset of Alzheimer's disease– related decline for adults with Down syndrome
por: Silverman, Wayne, et al.
Publicado: (2023)

The Association between Sex and Risk of Alzheimer’s Disease in Adults with Down Syndrome
por: Mhatre, Pooja Girish, et al.
Publicado: (2021)

An improved method for detecting telomere size differences in T-lymphocyte interphases from older people with Down syndrome with and without mild cognitive impairment
por: Jenkins, E. C., et al.
Publicado: (2017)

The Alzheimer's Biomarker Consortium‐Down Syndrome: Rationale and methodology
por: Handen, Benjamin L., et al.
Publicado: (2020)

Down syndrome: Distribution of brain amyloid in mild cognitive impairment
por: Keator, David B., et al.
Publicado: (2020)

Cognitive Function during the Prodromal Stage of Alzheimer’s Disease in Down Syndrome: Comparing Models
por: Hom, Christy L., et al.
Publicado: (2021)

Ophthalmic Disorders in Adults with Down Syndrome
por: Krinsky-McHale, Sharon J., et al.
Publicado: (2012)

A modified Cued Recall Test for detecting prodromal AD in adults with Down syndrome
por: Krinsky‐McHale, Sharon J., et al.
Publicado: (2022)

A Depressive Endophenotype of Mild Cognitive Impairment and Alzheimer’s Disease
por: Johnson, Leigh A., et al.
Publicado: (2013)

Language skills as a predictor of cognitive decline in adults with Down syndrome
por: Pulsifer, Margaret B., et al.
Publicado: (2020)

Metabolic correlates of prevalent mild cognitive impairment and Alzheimer's disease in adults with Down syndrome
por: Mapstone, Mark, et al.
Publicado: (2020)

Correction: Hom et al. Cognitive Function during the Prodromal Stage of Alzheimer’s Disease in Down Syndrome: Comparing Models. Brain Sci. 2021, 11, 1220
por: Hom, Christy L., et al.
Publicado: (2022)

Depressive Symptom Clusters and Neuropsychological Performance in Mild Alzheimer's and Cognitively Normal Elderly
por: Hall, James R., et al.
Publicado: (2011)

Accelerating Hyperparameter Tuning in Machine Learning for Alzheimer’s Disease With High Performance Computing
por: Zhang, Fan, et al.
Publicado: (2021)

Combination of Serum and Plasma Biomarkers Could Improve Prediction Performance for Alzheimer’s Disease
por: Zhang, Fan, et al.
Publicado: (2022)

Hyperparameter Tuning with High Performance Computing Machine Learning for Imbalanced Alzheimer’s Disease Data
por: Zhang, Fan, et al.
Publicado: (2022)

Characterizing Plasma Biomarkers of Alzheimer's in a Diverse Community-Based Cohort: A Cross-Sectional Study of the HAB-HD Cohort
por: Hall, James R., et al.
Publicado: (2022)

Cardiovascular Risk Factors, Cognitive Dysfunction, and Mild Cognitive Impairment
por: Vintimilla, Raul, et al.
Publicado: (2020)

Molecular markers of neuropsychological functioning and Alzheimer's disease
por: Edwards, Melissa, et al.
Publicado: (2015)

Obstructive sleep apnea, cerebrovascular disease, and amyloid in older adults with Down syndrome across the Alzheimer’s continuum
por: Lao, Patrick, et al.
Publicado: (2022)

Introduction to special issue on Advances in blood-based biomarkers of Alzheimer's disease
por: O'Bryant, Sid E.
Publicado: (2016)

A Precision Medicine Approach to Treating Alzheimer’s Disease Using Rosiglitazone Therapy: A Biomarker Analysis of the REFLECT Trials
por: O’Bryant, Sid E., et al.
Publicado: (2021)

Polymorphisms in HSD17B1: Early Onset and Increased Risk of Alzheimer's Disease in Women with Down Syndrome
por: Lee, Joseph H., et al.
Publicado: (2012)

APOEε4 Genotype Is Related to Brain Amyloid Among Mexican Americans in the HABS-HD Study
por: O'Bryant, Sid E., et al.
Publicado: (2022)

Acute Regression in Down Syndrome
por: Handen, Benjamin, et al.
Publicado: (2021)

Plasma Total Tau and Neurobehavioral Symptoms of Cognitive Decline in Cognitively Normal Older Adults
por: Hall, James R., et al.
Publicado: (2021)

Depression is differentially related to cognitive and biomarker outcomes among Mexican Americans
por: O’Bryant, Sid E., et al.
Publicado: (2022)

Joint‐label fusion brain atlases for dementia research in Down syndrome
por: Queder, Nazek, et al.
Publicado: (2022)

Parkinson’s Disease Blood Test for Primary Care
por: O’Bryant, Sid E., et al.
Publicado: (2022)

Potential two-step proteomic signature for Parkinson's disease: Pilot analysis in the Harvard Biomarkers Study
por: O'Bryant, Sid E., et al.
Publicado: (2019)

A blood screening tool for detecting mild cognitive impairment and Alzheimer's disease among community‐dwelling Mexican Americans and non‐Hispanic Whites: A method for increasing representation of diverse populations in clinical research
por: O'Bryant, Sid E., et al.
Publicado: (2021)

The Link between Potassium and Mild Cognitive Impairment in Mexican-Americans
por: Vintimilla, Raul M., et al.
Publicado: (2018)

Arsenic exposure, AS3MT polymorphism, and neuropsychological functioning among rural dwelling adults and elders: a cross-sectional study
por: Edwards, Melissa, et al.
Publicado: (2014)

Impact of the COVID-19 pandemic on daily life, mood, and behavior of adults with Down syndrome
por: Hartley, Sigan L., et al.
Publicado: (2022)

Timing of Alzheimer’s Disease by Intellectual Disability Level in Down Syndrome
por: Hartley, Sigan L., et al.
Publicado: (2023)

Application of Structural Retinal Biomarkers to Detect Cognitive Impairment in a Primary Care Setting
por: Mozdbar, Sima, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_i0683vo5laoii2l7p9b4nlr47h